Clinical Pharmacokinetics · 2016 · 211 citations · 18 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesBispecific AntibodiesBispecific Antibody TherapyCancer ImmunotherapyImmunotherapy For Solid TumorsT Cell Responses To TumorsBispecific Cell Engager DesignBlinatumomab TherapyCancer Antigen 19-9Cd19-directed Bispecific AntibodiesClinical Pharmacology EvidenceImmune Checkpoint BispecificsTargeted Immunotherapy
18
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
Ralf C. Bargou, Eugen Leo, Gerhard Zugmaier et al. · Science · 2008 · 1.1K citations
Life Sciences, Immunology, Oncology +17
Matthias Klinger, Christian Brandl, Gerhard Zugmaier et al. · Blood · 2012 · 463 citations